353 related articles for article (PubMed ID: 20444936)
1. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Dreams for type 1 diabetes: shutting off autoimmunity and stimulating beta-cell regeneration.
Weir GC; Bonner-Weir S
Endocrinology; 2010 Jul; 151(7):2971-3. PubMed ID: 20570953
[No Abstract] [Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
5. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
Reimer MK; Holst JJ; Ahrén B
Eur J Endocrinol; 2002 May; 146(5):717-27. PubMed ID: 11980629
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
Luo X; Tarbell KV; Yang H; Pothoven K; Bailey SL; Ding R; Steinman RM; Suthanthiran M
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2821-6. PubMed ID: 17307871
[TBL] [Abstract][Full Text] [Related]
7. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S
Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
[TBL] [Abstract][Full Text] [Related]
8. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
10. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
Suarez-Pinzon WL; Rabinovitch A
Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
[TBL] [Abstract][Full Text] [Related]
12. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.
Ansarullah ; Lu Y; Holstein M; DeRuyter B; Rabinovitch A; Guo Z
PLoS One; 2013; 8(1):e53345. PubMed ID: 23382843
[TBL] [Abstract][Full Text] [Related]
13. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)- pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV.
Hughes TE; Mone MD; Russell ME; Weldon SC; Villhauer EB
Biochemistry; 1999 Sep; 38(36):11597-603. PubMed ID: 10512614
[TBL] [Abstract][Full Text] [Related]
14. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
[TBL] [Abstract][Full Text] [Related]
15. The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats.
Furrer D; Kaufmann K; Tschuor F; Reusch CE; Lutz TA
Vet J; 2010 Mar; 183(3):355-7. PubMed ID: 19128990
[TBL] [Abstract][Full Text] [Related]
16. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
17. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
18. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
20. 16,17-Dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and β-cell proliferation in diabetic rat.
Shukla A; Srinivasan BP
Eur J Pharm Sci; 2012 Sep; 47(2):512-9. PubMed ID: 22820565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]